Literature DB >> 11018017

Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.

R Sears1, F Nuckolls, E Haura, Y Taya, K Tamai, J R Nevins.   

Abstract

Our recent work has shown that activation of the Ras/Raf/ERK pathway extends the half-life of the Myc protein and thus enhances the accumulation of Myc activity. We have extended these observations by investigating two N-terminal phosphorylation sites in Myc, Thr 58 and Ser 62, which are known to be regulated by mitogen stimulation. We now show that the phosphorylation of these two residues is critical for determining the stability of Myc. Phosphorylation of Ser 62 is required for Ras-induced stabilization of Myc, likely mediated through the action of ERK. Conversely, phosphorylation of Thr 58, likely mediated by GSK-3 but dependent on the prior phosphorylation of Ser 62, is associated with degradation of Myc. Further analysis demonstrates that the Ras-dependent PI-3K pathway is also critical for controlling Myc protein accumulation, likely through the control of GSK-3 activity. These observations thus define a synergistic role for multiple Ras-mediated phosphorylation pathways in the control of Myc protein accumulation during the initial stage of cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11018017      PMCID: PMC316970          DOI: 10.1101/gad.836800

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  63 in total

1.  Signal transduction within the nucleus by mitogen-activated protein kinase.

Authors:  A Seth; F A Gonzalez; S Gupta; D L Raden; R J Davis
Journal:  J Biol Chem       Date:  1992-12-05       Impact factor: 5.157

2.  Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates.

Authors:  W J Boyle; P van der Geer; T Hunter
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

3.  Rac and Cdc42 induce actin polymerization and G1 cell cycle progression independently of p65PAK and the JNK/SAPK MAP kinase cascade.

Authors:  N Lamarche; N Tapon; L Stowers; P D Burbelo; P Aspenström; T Bridges; J Chant; A Hall
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

4.  Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis.

Authors:  B Lutterbach; S R Hann
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

5.  Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo.

Authors:  B J Pulverer; C Fisher; K Vousden; T Littlewood; G Evan; J R Woodgett
Journal:  Oncogene       Date:  1994-01       Impact factor: 9.867

6.  Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas.

Authors:  K Bhatia; K Huppi; G Spangler; D Siwarski; R Iyer; I Magrath
Journal:  Nat Genet       Date:  1993-09       Impact factor: 38.330

7.  A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice.

Authors:  A C Davis; M Wims; G D Spotts; S R Hann; A Bradley
Journal:  Genes Dev       Date:  1993-04       Impact factor: 11.361

8.  Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene.

Authors:  J Charron; B A Malynn; P Fisher; V Stewart; L Jeannotte; S P Goff; E J Robertson; F W Alt
Journal:  Genes Dev       Date:  1992-12       Impact factor: 11.361

9.  Mutations in the coding region of c-MYC in AIDS-associated and other aggressive lymphomas.

Authors:  H M Clark; T Yano; T Otsuki; E S Jaffe; D Shibata; M Raffeld
Journal:  Cancer Res       Date:  1994-07-01       Impact factor: 12.701

10.  Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential.

Authors:  M Henriksson; A Bakardjiev; G Klein; B Lüscher
Journal:  Oncogene       Date:  1993-12       Impact factor: 9.867

View more
  530 in total

Review 1.  GSK-3: tricks of the trade for a multi-tasking kinase.

Authors:  Bradley W Doble; James R Woodgett
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

2.  Systemic elevation of PTEN induces a tumor-suppressive metabolic state.

Authors:  Isabel Garcia-Cao; Min Sup Song; Robin M Hobbs; Gaelle Laurent; Carlotta Giorgi; Vincent C J de Boer; Dimitrios Anastasiou; Keisuke Ito; Atsuo T Sasaki; Lucia Rameh; Arkaitz Carracedo; Matthew G Vander Heiden; Lewis C Cantley; Paolo Pinton; Marcia C Haigis; Pier Paolo Pandolfi
Journal:  Cell       Date:  2012-03-06       Impact factor: 41.582

3.  Specificity in the activation and control of transcription factor E2F-dependent apoptosis.

Authors:  Timothy C Hallstrom; Joseph R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-03       Impact factor: 11.205

4.  Myc degradation: dancing with ubiquitin ligases.

Authors:  Bruno Amati
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-08       Impact factor: 11.205

5.  Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins.

Authors:  Caroline Bouchard; Judith Marquardt; Alexandra Brás; René H Medema; Martin Eilers
Journal:  EMBO J       Date:  2004-07-08       Impact factor: 11.598

Review 6.  Integrin signalling and the cellular response to ionizing radiation.

Authors:  Nils Cordes; Viktor Meineke
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

7.  The Myc and Ras Partnership in Cancer: Indistinguishable Alliance or Contextual Relationship?

Authors:  Wadie D Mahauad-Fernandez; Dean W Felsher
Journal:  Cancer Res       Date:  2020-07-30       Impact factor: 12.701

Review 8.  PIM1: a promising target in patients with triple-negative breast cancer.

Authors:  Wen Zhao; RuiYue Qiu; Pan Li; Jin Yang
Journal:  Med Oncol       Date:  2017-07-18       Impact factor: 3.064

Review 9.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

Review 10.  Physiological roles of glycogen synthase kinase-3: potential as a therapeutic target for diabetes and other disorders.

Authors:  J R Woodgett
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2003-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.